Andere Kunden interessierten sich auch für
![IMPACT OF CORPORATE GOVERNANCE ON WORKING CAPITAL MANAGEMENT]( "IMPACT OF CORPORATE GOVERNANCE ON WORKING CAPITAL MANAGEMENT")
IMPACT OF CORPORATE GOVERNANCE ON WORKING CAPITAL MANAGEMENT26,99 €![Working Capital Management Efficiency of Indian Cement Industry]( "Working Capital Management Efficiency of Indian Cement Industry")
Working Capital Management Efficiency of Indian Cement Industry50,99 €![A Study on Capital Structure of Pharmaceutical Industry]( "A Study on Capital Structure of Pharmaceutical Industry")
A Study on Capital Structure of Pharmaceutical Industry46,99 €![Internationalization of Indian Pharmaceutical Industry]( "Internationalization of Indian Pharmaceutical Industry")
Internationalization of Indian Pharmaceutical Industry51,99 €![Open Innovation in the Pharmaceutical Industry]( "Open Innovation in the Pharmaceutical Industry")
Open Innovation in the Pharmaceutical Industry32,99 €![A Study of the Indian Pharmaceutical Industry in the New Patent Regime]( "A Study of the Indian Pharmaceutical Industry in the New Patent Regime")
A Study of the Indian Pharmaceutical Industry in the New Patent Regime51,99 €![Indian Patent Laws and the Domestic Pharmaceutical Industry]( "Indian Patent Laws and the Domestic Pharmaceutical Industry")
Indian Patent Laws and the Domestic Pharmaceutical Industry39,99 €
The study attempt to analyze the working capital efficiency of the domestic and multinational pharmaceutical companies during the boom, recession and recovery period. The study also explored the impact of working capital financing policies on the working capital efficiency of the domestic and multinational pharma companies during the boom, recession and recovery periods. Financial tools like utilization index, performance index, efficiency index, ratios and statistical tools like mean, grand mean, t-test, ANOVA and regression analysis has been deployed to draw inferences. The study found that the working capital efficiency index of the boom, recession and recovery period of the domestic pharmaceutical companies do not depict statistically significant difference and similar results are revealed by the study for the multinational pharma companies. Even the analysis shows that statistically the working capital management practices of the domestic pharmaceutical companies are at par with their counterparts i.e. multinational pharmaceutical companies as there is no significant difference in the working capital efficiency index.